Spectrum Pharmaceuticals
AstraZeneca
Eli Lilly and Co.
Bayer AG
GlaxoSmithKline PLC
Accredo Health Group Inc.
Teva Pharmaceuticals
Baxter International Inc.
F. Hoffmann La-Roche Ltd
Celgene Corp.
Table of Content
1 Introduction
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2028)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 Key Findings of the Study
3 Market Dynamics
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Non-Hodgkin Lymphoma Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Non-Hodgkin Lymphoma Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 Value Chain of the Non-Hodgkin Lymphoma Market
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 Global Non-Hodgkin Lymphoma Market-Segmentation by Type
5.1 B-Cell Lymphomas
5.2 T-Cell Lymphoma
6 Global Non-Hodgkin Lymphoma Market-Segmentation by Application
6.1 Hematology
6.2 Oncology
6.3 Others
7 Global Non-Hodgkin Lymphoma Market-Segmentation by Marketing Channel
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 Competitive Intelligence - Company Profiles
8.1 Spectrum Pharmaceuticals
8.1.1 Spectrum Pharmaceuticals Profile
8.1.2 Spectrum Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.1.3 Spectrum Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.1.4 Spectrum Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.2 AstraZeneca
8.2.1 AstraZeneca Profile
8.2.2 AstraZeneca Sales, Growth Rate and Global Market Share from 2015-2020
8.2.3 AstraZeneca Product/Solution Launches and Enhancements Analysis
8.2.4 AstraZeneca Business Overview/Recent Development/Acquisitions
8.3 Eli Lilly and Co.
8.3.1 Eli Lilly and Co. Profile
8.3.2 Eli Lilly and Co. Sales, Growth Rate and Global Market Share from 2015-2020
8.3.3 Eli Lilly and Co. Product/Solution Launches and Enhancements Analysis
8.3.4 Eli Lilly and Co. Business Overview/Recent Development/Acquisitions
8.4 Bayer AG
8.4.1 Bayer AG Profile
8.4.2 Bayer AG Sales, Growth Rate and Global Market Share from 2015-2020
8.4.3 Bayer AG Product/Solution Launches and Enhancements Analysis
8.4.4 Bayer AG Business Overview/Recent Development/Acquisitions
8.5 GlaxoSmithKline PLC
8.5.1 GlaxoSmithKline PLC Profile
8.5.2 GlaxoSmithKline PLC Sales, Growth Rate and Global Market Share from 2015-2020
8.5.3 GlaxoSmithKline PLC Product/Solution Launches and Enhancements Analysis
8.5.4 GlaxoSmithKline PLC Business Overview/Recent Development/Acquisitions
8.6 Accredo Health Group Inc.
8.6.1 Accredo Health Group Inc. Profile
8.6.2 Accredo Health Group Inc. Sales, Growth Rate and Global Market Share from 2015-2020
8.6.3 Accredo Health Group Inc. Product/Solution Launches and Enhancements Analysis
8.6.4 Accredo Health Group Inc. Business Overview/Recent Development/Acquisitions
8.7 Teva Pharmaceuticals
8.7.1 Teva Pharmaceuticals Profile
8.7.2 Teva Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.7.3 Teva Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.7.4 Teva Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.8 Baxter International Inc.
8.8.1 Baxter International Inc. Profile
8.8.2 Baxter International Inc. Sales, Growth Rate and Global Market Share from 2015-2020
8.8.3 Baxter International Inc. Product/Solution Launches and Enhancements Analysis
8.8.4 Baxter International Inc. Business Overview/Recent Development/Acquisitions
8.9 F. Hoffmann La-Roche Ltd
8.9.1 F. Hoffmann La-Roche Ltd Profile
8.9.2 F. Hoffmann La-Roche Ltd Sales, Growth Rate and Global Market Share from 2015-2020
8.9.3 F. Hoffmann La-Roche Ltd Product/Solution Launches and Enhancements Analysis
8.9.4 F. Hoffmann La-Roche Ltd Business Overview/Recent Development/Acquisitions
8.10 Celgene Corp.
8.10.1 Celgene Corp. Profile
8.10.2 Celgene Corp. Sales, Growth Rate and Global Market Share from 2015-2020
8.10.3 Celgene Corp. Product/Solution Launches and Enhancements Analysis
8.10.4 Celgene Corp. Business Overview/Recent Development/Acquisitions
9 Global Non-Hodgkin Lymphoma Market-Segmentation by Geography
10 North America
10.1 North America Non-Hodgkin Lymphoma Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Non-Hodgkin Lymphoma Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Non-Hodgkin Lymphoma Production Analysis from 2015-2020
10.4 North America Non-Hodgkin Lymphoma Consumption Analysis from 2015-2020
10.5 North America Non-Hodgkin Lymphoma Import and Export from 2015-2020
10.6 North America Non-Hodgkin Lymphoma Value, Production and Market Share by Type (2015-2020)
10.7 North America Non-Hodgkin Lymphoma Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Non-Hodgkin Lymphoma by Country (United States, Canada)
10.8.1 North America Non-Hodgkin Lymphoma Sales by Country (2015-2020)
10.8.2 North America Non-Hodgkin Lymphoma Consumption Value by Country (2015-2020)
10.9 North America Non-Hodgkin Lymphoma Market PEST Analysis
11 Europe
11.1 Europe Non-Hodgkin Lymphoma Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Non-Hodgkin Lymphoma Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Non-Hodgkin Lymphoma Production Analysis from 2015-2020
11.4 Europe Non-Hodgkin Lymphoma Consumption Analysis from 2015-2020
11.5 Europe Non-Hodgkin Lymphoma Import and Export from 2015-2020
11.6 Europe Non-Hodgkin Lymphoma Value, Production and Market Share by Type (2015-2020)
11.7 Europe Non-Hodgkin Lymphoma Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Non-Hodgkin Lymphoma by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Non-Hodgkin Lymphoma Sales by Country (2015-2020)
11.8.2 Europe Non-Hodgkin Lymphoma Consumption Value by Country (2015-2020)
11.9 Europe Non-Hodgkin Lymphoma Market PEST Analysis
12 Asia-Pacific
12.1 Asia-Pacific Non-Hodgkin Lymphoma Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Non-Hodgkin Lymphoma Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Non-Hodgkin Lymphoma Production Analysis from 2015-2020
12.4 Asia-Pacific Non-Hodgkin Lymphoma Consumption Analysis from 2015-2020
12.5 Asia-Pacific Non-Hodgkin Lymphoma Import and Export from 2015-2020
12.6 Asia-Pacific Non-Hodgkin Lymphoma Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Non-Hodgkin Lymphoma Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Non-Hodgkin Lymphoma by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Non-Hodgkin Lymphoma Sales by Country (2015-2020)
12.8.2 Asia-Pacific Non-Hodgkin Lymphoma Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Non-Hodgkin Lymphoma Market PEST Analysis
13 Latin America
13.1 Latin America Non-Hodgkin Lymphoma Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Non-Hodgkin Lymphoma Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Non-Hodgkin Lymphoma Production Analysis from 2015-2020
13.4 Latin America Non-Hodgkin Lymphoma Consumption Analysis from 2015-2020
13.5 Latin America Non-Hodgkin Lymphoma Import and Export from 2015-2020
13.6 Latin America Non-Hodgkin Lymphoma Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Non-Hodgkin Lymphoma Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Non-Hodgkin Lymphoma by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Non-Hodgkin Lymphoma Sales by Country (2015-2020)
13.8.2 Latin America Non-Hodgkin Lymphoma Consumption Value by Country (2015-2020)
13.9 Latin America Non-Hodgkin Lymphoma Market PEST Analysis
14 Middle East & Africa
14.1 Middle East & Africa Non-Hodgkin Lymphoma Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Non-Hodgkin Lymphoma Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Non-Hodgkin Lymphoma Production Analysis from 2015-2020
14.4 Middle East & Africa Non-Hodgkin Lymphoma Consumption Analysis from 2015-2020
14.5 Middle East & Africa Non-Hodgkin Lymphoma Import and Export from 2015-2020
14.6 Middle East & Africa Non-Hodgkin Lymphoma Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Non-Hodgkin Lymphoma Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Non-Hodgkin Lymphoma by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Non-Hodgkin Lymphoma Sales by Country (2015-2020)
14.8.2 Middle East & Africa Non-Hodgkin Lymphoma Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Non-Hodgkin Lymphoma Market PEST Analysis
15 Future Forecast of the Global Non-Hodgkin Lymphoma Market from 2020-2028
15.1 Future Forecast of the Global Non-Hodgkin Lymphoma Market from 2020-2028 Segment by Region
15.2 Global Non-Hodgkin Lymphoma Production and Growth Rate Forecast by Type (2020-2028)
15.3 Global Non-Hodgkin Lymphoma Consumption and Growth Rate Forecast by Application (2020-2028)
16 Appendix
16.1 Methodology
16.2 Research Data Source
